Skip to main content

HHS takes steps to provide more information about clinical trials to the public

On Sept. 16, 2016, in an effort to make information about clinical trials widely available to the public, the U.S. Department of Health and Human Services (HHS) issued a final rule specifying requirements for registering and reporting summary results information to The new rule expands the legal requirements for submitting registration and results information for certain clinical trials involving U.S. Food and Drug Administration (FDA)-regulated drug, biological and device products to At the same time, the National Institutes of Health issued a complementary policy for registering and submitting summary results information to for all NIH-funded clinical trials, including those not subject to the final rule. These actions are important steps to honor our commitments to clinical trial participants to share the knowledge gained from their participation in order to achieve the greatest benefit to human health.

Read the NIH news release along with related materials to learn more about these important developments.